July 10, 2017 / 9:02 PM / in 14 days

BRIEF-Arena Pharmaceuticals reports topline phase 2 results for Ralinepag

1 Min Read

July 10 (Reuters) - Arena Pharmaceuticals Inc :

* Arena pharmaceuticals reports positive topline phase 2 results for Ralinepag in patients with pulmonary arterial hypertension

* Safety data of phase 2 trial for ralinepag consistent with other drugs acting through prostacyclin receptor-mediated effects

* Says Ralinepag also demonstrated numerical improvement in 6-minute walk distance

* Primary efficacy analysis successful in phase 2 trial for Ralinepag; significant improvement in pulmonary vascular resistance Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below